FindTrial
Sign In

Identification and multicentral clinical validation of plasma diagnostic biomarkers for gastric cancer based on wide-targeted and targeted metabolomics

Identification and multicentral clinical validation of plasma diagnostic biomarkers for gastric cancer based on wide-targeted metabolomics

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300077764
Enrollment
Unknown
Registered
2023-11-20
Start date
2023-11-20
Completion date
Unknown
Last updated
2023-11-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastric cancer

Interventions

Healthy control group:None
Gastric Benign Disease Group:None
Early gastric cancer group:None
Progressive gastric cancer group:None

Sponsors

Beijing Friendship Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: - Confirmed diagnosis of gastric cancer or benign gastric diseases through gastroscopy and pathological examination. - Collection of plasma samples prior to surgical treatment. - Availability of complete clinical data.

Exclusion criteria

Exclusion criteria: - Previous reception of anti-tumor treatments (including radiotherapy, chemotherapy, etc.) before blood collection. - Coexistence of other systemic tumors. - Absence of plasma sample collection before surgical treatment. - Incomplete clinical data. - Pregnancy status.

Design outcomes

Primary

MeasureTime frame
Plasma metabolite content;—

Secondary

MeasureTime frame
The correlation between metabolite quantification results and clinical information;—

Countries

China

Contacts

Public ContactMin Li

Beijing Friendship Hospital, Capital Medical University

minli@ccmu.edu.cn+86 135 5265 2141

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026